Cargando…
Investigation of ATM, TP53 and MDM2 polymorphisms and their association with outcome of radiotherapy for prostate cancer
Autores principales: | Cintra, Hellen S, Pinezi, Juliana CD, Carvalho, Ana Terra S, Santos, Thalles ED, Marciano, Ricardo D, Soares, Renata BA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624166/ http://dx.doi.org/10.1186/1753-6561-7-S2-P29 |
Ejemplares similares
-
Investigation of Genetic Polymorphisms Related to the Outcome of Radiotherapy for Prostate Cancer Patients
por: Cintra, Hellen Silva, et al.
Publicado: (2013) -
Assesment of normal tissue radiosensitivity in cervical tumors
por: Carvalho, Ana TS, et al.
Publicado: (2013) -
Impact on breast cancer susceptibility and clinicopathological traits of common genetic polymorphisms in TP53, MDM2 and ATM genes in Sardinian women
por: Floris, Matteo, et al.
Publicado: (2022) -
Effects of MDM2, MDM4 and TP53 Codon 72 Polymorphisms on Cancer Risk in a Cohort Study of Carriers of TP53 Germline Mutations
por: Fang, Shenying, et al.
Publicado: (2010) -
MDM4 expression as an indicator of TP53 reactivation by combined targeting of MDM2 and MDM4 in cancer cells without TP53 mutation
por: Hirose, Mitsuaki, et al.
Publicado: (2014)